Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor vs Clopidogrel on Inflammatory Biomarkers in STEMI
NCT02123004Phase 4Unknown
- Sponsor
- Central Hospital Affiliated to Shandong First Medical University
- Start
- Apr 2014
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor in ST-segment elevation myocardial infarction (STEMI), sponsored by Central Hospital Affiliated to Shandong First Medical University. Status: unknown.
02
Drugs
ticagrelor
03
Conditions
ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT02123004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02123004.